The mouse Char10 locus regulates severity of pyruvate kinase deficiency and susceptibility to malariaReport as inadecuate




The mouse Char10 locus regulates severity of pyruvate kinase deficiency and susceptibility to malaria - Download this document for free, or read online. Document in PDF available to download.

Pyruvate kinase PKLR deficiency protects mice and humans against blood-stage malaria. Although mouse strain AcB62 carries a malaria-protective PklrI90N genetic mutation, it is phenotypically susceptible to blood stage malaria induced by infection with Plasmodium chabaudi AS, suggesting a genetic modifier of the PklrI90N protective effect. Linkage analysis in a F2 cross between AcB62 PklrI90N and another PK deficient strain CBA-Pk PklrG338D maps this modifier designated Char10 to chromosome 9 LOD = 10.8, 95% Bayesian CI = 50.7–75Mb. To study the mechanistic basis of the Char10 effect, we generated an incipient congenic line Char10C that harbors the Char10 chromosome 9 segment from AcB62 fixed on the genetic background of CBA-Pk. The Char10 effect is shown to be highly penetrant as the Char10C line recapitulates the AcB62 phenotype, displaying high parasitemia following P. chabaudi infection, compared to CBA-Pk. Char10C mice also display a reduction in anemia phenotypes associated with the PklrG338D mutation including decreased splenomegaly, decreased circulating reticulocytes, increased density of mature erythrocytes, increased hematocrit, as well as decreased iron overload in kidney and liver and decreased serum iron. Erythroid lineage analyses indicate that the number of total TER119+ cells as well as the numbers of the different CD71+-CD44+ erythroblast sub-populations were all found to be lower in Char10C spleen compared to CBA-Pk. Char10C mice also displayed lower number of CFU-E per spleen compared to CBA-Pk. Taken together, these results indicate that the Char10 locus modulates the severity of pyruvate kinase deficiency by regulating erythroid responses in the presence of PK-deficiency associated haemolytic anemia.



Author: Aurélie Laroque, Gundula Min-Oo, Mifong Tam, Prem Ponka, Mary M. Stevenson, Philippe Gros

Source: http://plos.srce.hr/



DOWNLOAD PDF




Related documents